BMC Cancer (May 2022)

Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma

  • Heng Ma,
  • Peng-Hui Feng,
  • Shuang-ni Yu,
  • Zhao-Hui Lu,
  • Qi Yu,
  • Jie Chen

DOI
https://doi.org/10.1186/s12885-022-09692-0
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 1

Abstract

Read online

No abstracts available.